Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 12, 2023
DURHAM, N.C., May 05, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq:HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, will release its financial results for the first quarter ended March 31, 2023, on Friday, May 12, 2023. Management will host a webcast and conference call at 8:00 a.m. ET to provide a corporate and financial update.
Related news for (HUMA)
- Humacyte Announces Publication of Long-Term Results for Ukrainian Patients Treated in Real-World Combat Setting with Symvess™
- MoBot’s Stock Market Highlights – 10/06/25 01:00 PM
- 24/7 Market News Snapshot 06 October, 2025 – Humacyte, Inc. Common Stock (NASDAQ:HUMA)
- MoBot’s Stock Market Highlights – 07/23/25 10:00 AM
- 24/7 Market News Snapshot 23 July, 2025 – Humacyte, Inc. Common Stock (NASDAQ:HUMA)
